Clinical Trial Update: Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing inhaled corticosteroids ciclesonide and fluticasone propionate in adults with moderate-to-severe persistent asthma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)
• ciclesonide (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED